299 related articles for article (PubMed ID: 21053778)
1. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
[TBL] [Abstract][Full Text] [Related]
2. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
4. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
[TBL] [Abstract][Full Text] [Related]
5. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
6. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
8. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
[TBL] [Abstract][Full Text] [Related]
9. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
10. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
11. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding L7/L12-P39 of Brucella abortus induces protective immunity in BALB/c mice.
Luo DY; Li P; Xing L; Zhao GY; Shi W; Zhang SL; Wang XL
Chin Med J (Engl); 2006 Feb; 119(4):331-4. PubMed ID: 16537031
[No Abstract] [Full Text] [Related]
13. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
Pontes DS; Dorella FA; Ribeiro LA; Miyoshi A; Le Loir Y; Gruss A; Oliveira SC; Langella P; Azevedo V
J Drug Target; 2003; 11(8-10):489-93. PubMed ID: 15203917
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
15. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
17. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
Singh D; Goel D; Bhatnagar R
Vaccine; 2015 Jun; 33(24):2786-92. PubMed ID: 25930114
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.
Kurar E; Splitter GA
Vaccine; 1997 Dec; 15(17-18):1851-7. PubMed ID: 9413093
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
20. Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.
Singha H; Mallick AI; Jana C; Fatima N; Owais M; Chaudhuri P
Vaccine; 2011 Jun; 29(29-30):4720-7. PubMed ID: 21565241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
